Martin Smith
Chief Tech/Sci/R&D Officer bei IDEXX LABORATORIES, INC.
Vermögen: 256 467 $ am 31.03.2024
Profil
Martin Alexander Smith is currently the Chief Technology Officer & Executive VP at IDEXX Laboratories, Inc. Prior to this, he held the position of Chief Technology Officer at Pall Corp.
from 2014 to 2020.
He also served as the Chief Technology Officer & Vice President at Cytiva from 2020 to 2021.
Dr. Smith's education includes a graduate degree from The University of Reading, an undergraduate degree from the University of Essex, and a doctorate from University College London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IDEXX LABORATORIES, INC.
0,00% | 14.02.2024 | 475 ( 0,00% ) | 256 467 $ | 31.03.2024 |
Aktive Positionen von Martin Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| IDEXX LABORATORIES, INC. | Chief Tech/Sci/R&D Officer | 01.08.2021 |
Ehemalige bekannte Positionen von Martin Smith
| Unternehmen | Position | Ende |
|---|---|---|
Global Life Sciences Solutions USA LLC
 Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a private company that manufactures therapeutics. The company is based in Marlborough, MA. | Chief Tech/Sci/R&D Officer | 01.07.2021 |
| PALL CORPORATION | Chief Tech/Sci/R&D Officer | 01.08.2020 |
Ausbildung von Martin Smith
| The University of Reading | Graduate Degree |
| University of Essex | Undergraduate Degree |
| University College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IDEXX LABORATORIES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a private company that manufactures therapeutics. The company is based in Marlborough, MA. | Health Technology |
